Genetic Testing Company Opens Up Trove Of Cancer Patient Data To Public

In a win for open data, leading diagnostics company Ambry Genetics is releasing genetic information from 10,000 patients with breast and ovarian cancer in a free, public database open to researchers studying genetic links to these diseases and others.